ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Sanofi

Sanofi (SANF)

0.00
0.00
( 0.00% )

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

SANF Últimas noticias

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma New Sarclisa subcutaneous formulation met co-primary endpoints in the...

Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple

Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple La nouvelle...

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins pneumococciques conjugués

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins...

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines Sanofi initiates phase 3 program for...

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors Jean-Paul Kress to join Sanofi's Board of Directors Paris, December 19, 2024. Sanofi's Board of Directors is pleased to...

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Paris, le 19 décembre 2024. Le Conseil...

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Duvakitug positive phase 2b results demonstrate best-in-class...

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de...

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire »

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire » Mise en ligne du document « Q4 2024 Aide-mémoire » Paris, France, le 17 Décembre 2024. Sanofi annonce la mise en ligne...

Press Release: Availability of the Q4 2024 Aide-mémoire

Press Release: Availability of the Q4 2024 Aide-mémoire Availability of the Q4 2024 Aide-mémoire Paris, France – December 17, 2024. Sanofi announced today that its Q4 2024 Aide-mémoire is...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

SANF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Sanofi?
El precio actual de las acciones de Sanofi es 0.00 €
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Sanofi?
Sanofi ha negociado en un rango de 0.00 € a 0.00 € durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WERFOLaboratorio Farmaceutico Erfo SPA
0.097 €
(29.33%)
500
BESBestbe Holding
0.718 €
(19.67%)
73.76k
ISCIntegrated System Credit Consulting Fintech Spa
2.34 €
(11.43%)
121.87k
FREFrendy Energy Spa
0.276 €
(10.40%)
978.48k
SIAVSiav Spa
2.20 €
(10.00%)
15.5k
WSBCCSicily by Car SpA
0.0289 €
(-27.75%)
12.69k
1UAAUnder Armour Inc
7.681 €
(-18.36%)
15
WTFINTrevi Finanziaria Industriale Spa
0.611 €
(-12.84%)
813
EGBEGlobe
0.945 €
(-9.13%)
27k
ELBEdgelab
6.60 €
(-8.98%)
29.5k
TITTelecom Italia SpA
0.2559 €
(-1.20%)
104.53M
ISPIntesa Sanpaolo Spa
4.005 €
(0.39%)
30.77M
SPMSaipem Spa
2.775 €
(0.76%)
16.7M
BMPSBanca Monte Dei Paschi Di Siena Spa
6.968 €
(-0.99%)
9.42M
TITRTelecom Italia
0.2967 €
(-0.57%)
9.03M
glenn1919 glenn1919 3 minutos hace
SENS.....................https://stockcharts.com/h-sc/ui?s=SENS&p=W&b=5&g=0&id=p86431144783
SENS
RIGATONI RIGATONI 3 minutos hace
Remember with most of these...

https://youtu.be/qbGFrrifeEs
uranium-pinto-beans uranium-pinto-beans 4 minutos hace
Todays top increases in stock option open interest $NVDA $MSTR $GOOGL $SNAP $RIOT $WOLD $GSAT $AMD
AMD GOOGL GSAT
marylandstockguy marylandstockguy 4 minutos hace
Wow - how long did you stay in TSNP???
GTCH
marylandstockguy marylandstockguy 6 minutos hace
Thanks Cant - and good morning everyone! Just get us to March!
GTCH
ksquared ksquared 6 minutos hace
Our leaders praise ‘diversity’ without prioritizing what the public really needs
By Douglas Murray Published Jan. 9, 2025, 7:26 p.m. ET ... the truth is that nobody has time for this rubbish anymore. Things are too serious — in California and across this country — to keep p
Methinks Methinks 7 minutos hace
https://businesscrack.co.uk/2025/01/10/cyber-security-firm-launches-in-carlisle/
They need to promote Wave.
RIGATONI RIGATONI 7 minutos hace
.068 nice pre-market ^ traction ~Rig
glenn1919 glenn1919 7 minutos hace
STEM........................................https://stockcharts.com/h-sc/ui?s=STEM&p=W&b=5&g=0&id=p86431144783
STEM
Methinks Methinks 8 minutos hace
https://spectator.sme.sk/politics-and-society/c/news-digest-quite-possibly-the-worst-cyber-attack-in-history-of-slovakia?piano_t=1
Sort it with Wave.
sumbuysumsell sumbuysumsell 9 minutos hace
https://finance.yahoo.com/news/alzheimer-drugs-eyed-investors-seeking-050000316.html
AVXL
Methinks Methinks 9 minutos hace
https://cointelegraph.com/news/indian-crypto-exchange-wazir-x-charts-recovery-path-after-235-m-cyberattack
Wave could surely help with this recovery.
2221 2221 9 minutos hace
When the market realizes the true value there will be moass like never seen before..all aboard
FNMA
Invest-in-America Invest-in-America 11 minutos hace
VMAR: Are batteries for BOATS trending these days????? (But then, 'tiny' FLOATS --- no pun intended, behind 'MARINE' matters --- always send stocks SOARING, right???)
VMAR
harr449 harr449 11 minutos hace
Nice article
LUNR
tw0122 tw0122 12 minutos hace
NBY news .77 + 20%

....On January 3, 2025, NovaBay Pharmaceuticals, Inc. (the “Company”) entered into a Trademark Acquisition Agreement, (the “Trademark Acquisition Agreement”), by and between the Company and Phase One Health LLC, a Tennessee limited liability company (“Phase One”), t
NBY
EclipseDefender58 EclipseDefender58 14 minutos hace
You have a link for this reference?
FNMA
thesmallguy thesmallguy 14 minutos hace
Yes, it's definitely possible.
ASII
kip128932156 kip128932156 14 minutos hace
https://x.com/billackman/status/1877691302323597434?s=46&t=L_hszGlrG7Qfo9Ksmln_mQ
FNMA
tw0122 tw0122 15 minutos hace
AKYA QTRX merger  $4 + 50% 
AKYA
harr449 harr449 15 minutos hace
D-Wave Announces Fiscal Year 2024 Bookings Will Exceed $23 Million, Up Approximately 120% Over Fiscal Year 2023
First-ever customer purchase of D-Wave Advantage annealing quantum computing system in Q4 contributes to increased bookings and marks significant expansion of the company’s revenue
KULR
jay_tee jay_tee 15 minutos hace
No worries JMONEY said we have tons of free cash flow for unpaid bills, late fees, judgments, etc
RNVA
Lurker3 Lurker3 15 minutos hace
What a load of crapula and speculation based on nothing
LWLG
uranium-pinto-beans uranium-pinto-beans 16 minutos hace
WING
Wingstop added to Best Ideas List at Wedbush
Wedbush added Wingstop to the firm's Best Ideas List. The firm views Wingstop as well-positioned to deliver mid-single digit same-store sales growth in 2025 given its attractive value proposition and perception, and sees continued gr

Su Consulta Reciente

Delayed Upgrade Clock